Navigation Links
Implantable devices to be powered by organosilicon compounds in the future

Medical technology has advanced so much to the extent of replacing lost organs or improving function of existing ones using artificial implants. These implantable devices are becoming commonplace today by serving as a good // alternative to the conventional treatment.

Such effective utilization would not have been possible without the availability of lithium batteries that supply power, thereby ensuring functionality of these tiny, yet useful devices. Designed to be extraordinarily reliable and work continuously for years, the batteries that power implantables are indispensable in everything from pacemakers to the electronic stimulators that help restore function in the brains of Parkinson's patients.

However, lithium batteries don't last forever and new surgery to maintain many devices seeded into the body is required. It is both a physical and financial strain for the patient. In an attempt to ensure superior performance, scientists are now working on silicon-based compounds that are used in the treatment of nervous and other disorders. The unique rechargeable ability of the new generation battery confers twice as longer lifetime than the ones currently used.

This offers a new ray of hope in medical treatment as these new generation electrical devices could be used to stimulate the nervous system, treat incontinence and overcome muscular impairment.

Central to that ability and vision, is emerging a new lithium battery technology, capable of making batteries smaller, last longer and, soon, accept a charge from outside the body without the need for surgery. "It turns out the organosilicon compounds (compounds made of silicon and other natural materials) are really good for improving lithium battery technology," says West, one instrumental behind this significant development. The new battery technology powers a "microstimulater" not much larger than a pencil lead and can be injected near target nerves to help overcome t he faulty nervous system wiring at the heart of Parkinson's, epilepsy and incontinence.

They're very flexible, stable, nonflammable, non-toxic and do not pose a threat to the environment, according to the researchers. The average expected life span of these batteries is expected to be over 12 years. Furthermore, it makes use of Silicon, one of the Earth's most abundant elements.

In addition to implantable devices for medicine, lithium batteries are used in scores of applications, from spacecraft to iPods. We will have to watch and wait for some time before the power of these batteries can be exploited to the maximum.
'"/>




Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. New Implantable Device That Can Keep The Heart Ticking
3. Making MRIs Safe for Patients With Implantable Heart Devices
4. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
5. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
6. First Implantable artificial heart gets FDA’s approva
7. Futuristic devices are here to take care of dental problems
8. Cheap Indian devices sought to treat sleep disorder
9. Bionic muscles developed by scientists powered by alcohol and hydrogen
10. Patients Empowered to Force for Better Services
11. China Introduces Solar-powered Baths
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... ... , ... California Southern University has named Dr. Steven Beazley University President. ... as a core faculty member, teaching master’s and doctoral courses in the university’s School ... University, where he earned his Doctor of Psychology degree in 1998. Dr. Beazley also ...
(Date:1/16/2017)... ... , ... With the Grand Opening Event planned for February 3, 2017, the ... and the general public. Built in five months by Centerpoint, the 60,000 square foot ... or pickleball courts. The space is also suitable for indoor soccer and football training. ...
(Date:1/16/2017)... New York (PRWEB) , ... January 16, 2017 ... ... SightMD today announced the addition of Victor Giamos, MD to their ... of SightMD and Managing Partner at North Shore Eye Care, a division of ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... partnership with an innovator in the wheelchair accessibility industry, BraunAbility . Incentive ... salespeople to sell wheelchair accessible vehicles. With this new incentive plan, BraunAbility plans ...
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon ... , the official journal of The American Society for Aesthetic Plastic Surgery, in ... procedure is designed to correct drooping, retracted lower eyelids, which usually result from ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... BAUDETTE, Minn. , Jan. 17, 2017 /PRNewswire/ ... ) today announced the appointment of Karen Quinn ... January 17, 2017.  Karen ... years of leadership experience in Global Regulatory Affairs, ... biologically-derived active pharmaceutical ingredients.  Dr. Quinn worked most ...
(Date:1/17/2017)... pioneer in no-touch UV disinfection has now been validated by ... for "total room ultraviolet disinfection," was the device of choice ... study which was recently published in The Lancet ... transmission of four major superbugs by a cumulative 30 percent. ... we have been committed to innovation and the science behind ...
(Date:1/16/2017)... Research and Markets has announced the addition ... to their offering. ... Global multiple myeloma drugs market to grow at a CAGR ... covers the present scenario and the growth prospects of the global ... the report considers the revenue generated from the sales of branded ...
Breaking Medicine Technology: